GutCheck nabs $4M, aids Pfizer with consumer-research software

Denver-based market research startup GutCheck has found $4 million for a Series B round of financing. The deal provides more resources to the company whose software helps companies conduct one-on-one surveys with consumers with greater speed than traditional methods of gathering such information, CEO Matt Warta tells Xconomy. The U.S. drug giant Pfizer ($PFE) and other companies outside of the pharma business have used GutCheck's service. Article

Suggested Articles

Trialbee has added ex-Lundbeck CEO Ulf Wiinberg and former Bristol-Myers Squibb SVP Lars Birgerson to its board of directors.

Researchers have enrolled 2,000 people with metastatic breast cancer in 7 months using a social media-enabled, direct-to-patient model of recruiting.

Medisafe has started pitching an app and services to increase medication adherence and facilitate patient recruitment to biopharma companies.